Morgan Stanley Maintains BeiGene(BGNE.US) With Buy Rating, Cuts Target Price to $307
Evercore ISI Raises Price Target on Argenx to $555 From $533, Keeps Outperform Rating
Morgan Stanley Maintains BeiGene(BGNE.US) With Buy Rating, Cuts Target Price to $307
What 25 Analyst Ratings Have To Say About Argenx
J.P. Morgan Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $640
BeiGene Analyst Ratings
J.P. Morgan Maintains BeiGene(BGNE.US) With Buy Rating, Raises Target Price to $200
Buy Rating Affirmed: Overlooked Long-Term Benefits of Repligen's Potential Maravai Acquisition
Jefferies Maintains Repligen(RGEN.US) With Hold Rating, Cuts Target Price to $160
Jefferies Remains a Hold on Repligen (RGEN)
TD Cowen Initiates BeiGene(BGNE.US) With Buy Rating, Announces Target Price $254
TD Cowen Sticks to Its Buy Rating for BeiGene (BGNE)
Jefferies Maintains BeiGene(BGNE.US) With Buy Rating, Raises Target Price to $284
Jefferies Maintains BeiGene(BGNE.US) With Buy Rating, Raises Target Price to $284
Jefferies Sticks to Their Buy Rating for BeiGene (BGNE)
Illumina Analyst Ratings
Daiwa Initiates Illumina(ILMN.US) With Buy Rating, Announces Target Price $154
Scotiabank Maintains Illumina(ILMN.US) With Buy Rating, Cuts Target Price to $164
A Quick Look at Today's Ratings for Illumina(ILMN.US), With a Forecast Between $125 to $242
Illumina Analyst Ratings